4.7 Article

Recurrent Germline Variant in RAD21 Predisposes Children to Lymphoblastic Leukemia or Lymphoma

Journal

Publisher

MDPI
DOI: 10.3390/ijms23095174

Keywords

acute lymphoblastic leukemia; trio sequencing; germline cancer predisposition; RAD21; cohesin complex

Funding

  1. ERC [Stg 85222]
  2. Deutsche Krebshilfe (DKH) Excellenz Forderprorgamm [70114539]
  3. Deutsche Jose Carreras Leukamie-Stiftung e.V.
  4. Italian Association for Cancer Research (AIRC) [21999]
  5. Monza parents committee 'Comitato Maria Letizia Verga'
  6. ERA Per Med.JTC 2018 GEPARD
  7. COST (European Cooperation in Science and Technology) [CA16223]
  8. Deutsche Forschungsgemeinschaft (DFG) [JE150/31-1]
  9. Forschungskommission Heinrich Heine University Duesseldorf [2020-28]
  10. Gesellschaft fur Paediatrische Onkologie und Haematologie e.V
  11. Sonnenstrahl e.V

Ask authors/readers for more resources

Mutations in RAD21 gene in germline are associated with childhood lymphoblastic leukemia or lymphoma without CdLS phenotype.
Somatic loss of function mutations in cohesin genes are frequently associated with various cancer types, while cohesin disruption in the germline causes cohesinopathies such as Cornelia-de-Lange syndrome (CdLS). Here, we present the discovery of a recurrent heterozygous RAD21 germline aberration at amino acid position 298 (p.P298S/A) identified in three children with lymphoblastic leukemia or lymphoma in a total dataset of 482 pediatric cancer patients. While RAD21 p.P298S/A did not disrupt the formation of the cohesin complex, it altered RAD21 gene expression, DNA damage response and primary patient fibroblasts showed increased G2/M arrest after irradiation and Mitomycin-C treatment. Subsequent single-cell RNA-sequencing analysis of healthy human bone marrow confirmed the upregulation of distinct cohesin gene patterns during hematopoiesis, highlighting the importance of RAD21 expression within proliferating B- and T-cells. Our clinical and functional data therefore suggest that RAD21 germline variants can predispose to childhood lymphoblastic leukemia or lymphoma without displaying a CdLS phenotype.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available